Mucormycosis News and Research

RSS
FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

Astellas seeks isavuconazole approval from FDA for treatment of life-threatening fungal infections

Astellas seeks isavuconazole approval from FDA for treatment of life-threatening fungal infections

Astellas' isavuconazole receives QIDP designation from FDA for zygomycosis treatment

Astellas' isavuconazole receives QIDP designation from FDA for zygomycosis treatment

Study: Investigational drug effective in reducing mucormycosis infections

Study: Investigational drug effective in reducing mucormycosis infections

CotH protein mediates fungal invasion of host cells during mucormycosis

CotH protein mediates fungal invasion of host cells during mucormycosis

Research finding could lead to development of vaccine and therapies for mucormycosis

Research finding could lead to development of vaccine and therapies for mucormycosis

Apophysomyces fungus kills 5 people following a massive Joplin tornado

Apophysomyces fungus kills 5 people following a massive Joplin tornado